Telos(TLS) - 2024 Q4 - Earnings Call Transcript
2025-03-10 20:41
Financial Data and Key Metrics Changes - Total company revenue grew 11% sequentially to $26.4 million in Q4 2024, near the top end of the guidance range [9] - Adjusted EBITDA improved sequentially from a $4.2 million loss in Q3 to a $200,000 loss in Q4 [13][34] - GAAP gross margin expanded nearly 600 basis points year-over-year to 40.3%, while cash gross margin expanded nearly 900 basis points year-over-year to 47% [11] Business Line Data and Key Metrics Changes - Security solutions revenue grew 20% sequentially to $21.9 million, representing 83% of total company revenue [9] - Revenue from TSA PreCheck enrollments grew over 30% sequentially [9] - Secure Networks delivered $4.5 million of revenue, representing 17% of total company revenue, but declined sequentially as expected [10] Market Data and Key Metrics Changes - The TSA PreCheck program became the single largest program by revenue during 2024, with significant growth expected in 2025 [18] - The company increased its enrollment centers from 26 to 218 locations across the U.S. in 2024 [16] Company Strategy and Development Direction - The company is focusing on optimizing performance for customers and prioritizing task orders from existing contract vehicles due to delays in single awards [40] - The company aims to achieve a pro rata share of the TSA PreCheck enrollment market, targeting 500 locations by the end of 2025 [32] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the new administration being generally positive for the company, despite delays in single awards [40] - The company expects to generate positive cash flow in Q1 2025 and significant improvements in revenue, profit, and cash flow for the full year [36][61] Other Important Information - The company anticipates revenue for the full year 2025 to be driven by existing business, TSA PreCheck, and new programs with DMDC and DHS [29][30] - The company is experiencing delays in government awards due to changes in administration but is not seeing similar delays on task orders [23] Q&A Session Summary Question: Impact of the change in administration on single award programs - Management noted that while the new administration is generally positive, single awards are being held back for review, leading to a focus on task orders from existing contracts [40] Question: Details on revenue recognition for DMDC and DHS programs - Management clarified that the mix of third-party content is shifting towards software, affecting revenue recognition timing, with a partial year of revenue expected in the first year [44][45] Question: TSA PreCheck revenue projections based on current rollout - Management confirmed that the framework for TSA PreCheck revenue is correct, with expectations for revenue to ramp as more locations open [51] Question: Cash flow expectations for Q1 and the full year - Management indicated that Q1 cash flow will benefit from working capital liquidation and expects positive free cash flow for the year, with breakeven adjusted EBITDA around $155 million to $160 million in revenue [54][55]
DarioHealth(DRIO) - 2024 Q4 - Earnings Call Transcript
2025-03-10 20:41
DarioHealth (DRIO) Q4 2024 Earnings Call March 10, 2025 04:41 PM ET Company Participants Kat Parrella - Investor Relations ManagerErez Raphael - Chief Executive OfficerSteven Nelson - Chief Commercial OfficerCharles Rhyee - Managing DirectorAshok Kumar - Head of Equity ResearchDavid Grossman - Managing Director Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Fourth Quarter twenty twenty four Results Conference Call. This call is being recorded on Monday, 03/10/2025. I would now l ...
en & pany (COHN) - 2024 Q4 - Earnings Call Transcript
2025-03-10 20:21
Cohen & Company (COHN) Q4 2024 Earnings Call March 10, 2025 04:21 PM ET Company Participants Lester Brafman - Chief Executive OfficerJoseph Pooler - Executive VP, CFO & Treasurer Operator Good morning, ladies and gentlemen, and welcome to Cohen and Company's Fourth Quarter twenty twenty four Earnings Call. My name is Sherry, and I will be your operator for today. Before we begin, Cohen and Company would like to remind everyone that some of the statements the company makes during this call contain forward lo ...
Rand Capital(RAND) - 2024 Q4 - Earnings Call Transcript
2025-03-10 19:52
Financial Data and Key Metrics Changes - Total investment income increased by 11% to $2.1 million in Q4 2024, with full-year investment income rising 17% to $8.6 million compared to the previous year [10][36] - Net asset value per share grew by 7% year-over-year, reaching $25.31 at year-end [11][43] - Total expenses for Q4 2024 were a credit of $376,000, compared to an expense of $1 million in Q4 2023, primarily due to a decrease in capital gains incentive fee expense [37][38] Business Line Data and Key Metrics Changes - Debt investments now make up 75% of the portfolio, up from 64% in 2023, contributing to improved yields and earnings stability [12][21] - The annualized weighted average yield of debt investments was 13.8% as of December 31, 2024, an increase of 20 basis points over 2023 [22] - The number of portfolio companies contributing to investment income decreased from 26 in 2023 to 25 in 2024 [36] Market Data and Key Metrics Changes - The portfolio's fair value decreased by 8% from the end of 2023, primarily due to the successful exit from SciAps [20] - Exposure to professional services increased from 42% to 48%, while manufacturing and software saw a relative decline [28] Company Strategy and Development Direction - The company is focused on creating long-term value for shareholders through disciplined capital allocation and managing a more income-generating portfolio [15][50] - The strategic shift towards income-producing investments is expected to support sustained higher dividend levels over time [45] - The company aims to capitalize on opportunities in the lower middle market, particularly family-owned businesses facing succession challenges [49] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the potential for recovery in portfolio valuations, particularly if consumer spending stabilizes [55] - The company is monitoring macroeconomic trends, including potential interest rate reductions, which could enhance portfolio performance [15][52] - Management emphasized the importance of proactive risk management in navigating economic and political uncertainties [54] Other Important Information - The company declared a total of $4.3 million in cash dividends during 2024, with a quarterly cash dividend increase of 16% to $0.29 per share [14][45] - The company successfully exited its investment in SciAps, generating $13.1 million in total proceeds and a realized gain of $7.7 million [25] Q&A Session Summary Question: What are the expectations for future dividend growth? - Management indicated confidence in the ability to sustain and potentially increase dividends due to the strategic shift towards income-generating investments [45][55] Question: How does the company plan to navigate economic uncertainties? - The company plans to maintain a diversified portfolio and proactive risk management to adapt to changing market conditions [54][55]
Willis Lease(WLFC) - 2024 Q4 - Earnings Call Transcript
2025-03-10 19:26
Willis Lease Finance Corporation (NASDAQ:WLFC) Q4 2024 Earnings Conference Call March 10, 2025 10:00 AM ET Company Participants Austin Willis - Chief Executive Officer Scott Flaherty - Chief Financial Officer Conference Call Participants Louis Raffetto - Wolfe Research Eric Gregg - Four Tree Island Advisory Sergey Glinyanov - Freedom Broker William Waller - M3F, Inc. Operator Good day, and welcome to the Willis Lease Finance Corporation Fourth Quarter 2024 Earnings Call. Today's conference is being recorded ...
Fennec Pharma(FENC) - 2024 Q4 - Earnings Call Transcript
2025-03-10 18:55
Financial Data and Key Metrics Changes - In 2024, the company reported a revenue growth of approximately 40% year-over-year, with net product sales of $29.6 million compared to $21.3 million in 2023 [28][30] - For Q4 2024, net product sales were $7.9 million, reflecting a quarterly growth rate of approximately 13% [28] - The company managed to burn only approximately $0.6 million in cash for Q4 2024, demonstrating operational efficiency [34] Business Line Data and Key Metrics Changes - The pediatric segment continued to show growth, while the adolescent and young adult (AYA) segment emerged as a significant opportunity [38] - Selling and marketing expenses for Q4 2024 were $3.9 million, down from $4.6 million in Q3 2024, while full-year expenses increased to $18.4 million from $12.1 million in the previous year [29][30] Market Data and Key Metrics Changes - The U.S. AYA oncology landscape is estimated to have approximately 20,000 cisplatin chemotherapy patients treated annually, with significant market potential [11] - The product PEDMARK is gaining traction in major academic centers, which is critical for broader market acceptance [14] Company Strategy and Development Direction - The company is focused on expanding awareness of the unmet need for preventing cisplatin-induced ototoxicity and establishing PEDMARK as the standard of care [9][10] - The PEDMARK strategy will be utilized throughout 2025 to drive growth, with a focus on increasing adoption among oncologists and ensuring access for patients [7][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth potential for PEDMARK, particularly in the AYA segment, and anticipates significant growth in the second half of 2025 [41][42] - The company is actively engaging with stakeholders to support the inclusion of PEDMARK in key compendia, which is expected to enhance access and reimbursement pathways [17][18] Other Important Information - The company has launched PEDMARQSI in Germany and the U.K., with pricing set at £8277 in the U.K. and over €10,500 in Germany [20][21] - The company anticipates receiving a €10 million milestone upon obtaining final pricing approval in Germany [34] Q&A Session Summary Question: Did the pediatric business return to sequential growth in Q4, and what was the AYA contribution? - Management confirmed continued growth in the pediatric segment and highlighted the AYA segment as an incredible opportunity, though specific breakdowns were not provided [38] Question: What is the expected inflection in the AYA segment for 2025? - Management indicated significant opportunities in the AYA segment and expects accelerated growth in the second half of the year [41][42] Question: What progress has Norgine made in Europe regarding key centers of excellence? - Management noted that the product is now commercially available in the U.K. and Germany, with ongoing updates expected as more countries are approved [48][49] Question: What is the competitive landscape for PEDMARK in the U.S.? - Management acknowledged the presence of compounded products but emphasized the adoption of PEDMARK in major institutions, indicating progress despite competition [72] Question: Will clinical trials be run for potential label expansions? - Management indicated openness to discussions regarding label expansions and will provide updates as developments occur [75]
Genie Energy(GNE) - 2024 Q4 - Earnings Call Transcript
2025-03-10 18:50
Genie Energy (GNE) Q4 2024 Earnings Call March 10, 2025 02:50 PM ET Company Participants Michael Stein - CEOAvi Goldin - CFO Operator Good day, and welcome to the Genie Energy Limited's Fourth Quarter and Full Year twenty twenty four Earnings Call. In today's presentation, Genie Energy management will discuss Genie's financial and operational results for the three and twelve month periods ended 12/31/2024. During prepared remarks by Genie Energy's Chief Executive Officer, Michael Stein and Chief Financial O ...
Franco-Nevada(FNV) - 2024 Q4 - Earnings Call Transcript
2025-03-10 17:55
Financial Data and Key Metrics Changes - The company reported a strong fourth quarter with total GEO sales of 463,334, near the top end of the revised guidance range of 445,000 to 465,000 GEOs for 2024 [19][20] - Total revenue for Q4 2024 was $321 million, a 5.8% increase from $303.3 million in Q4 2023 [24] - Adjusted EBITDA for Q4 2024 was $277.4 million, up 9% from $254.6 million in Q4 2023 [24][28] - Adjusted net income for Q4 2024 was $183.3 million, or $0.95 per share, representing a 6% increase year-over-year [28] Business Line Data and Key Metrics Changes - Precious metal GEOs sold in Q4 2024 were 95,565, a 5% increase compared to the prior year when excluding Cobre Panama [22] - The diversified assets contributed just over 108,000 GEOs sold for the year, with revenue from these assets in line with expectations [21] - Candelaria delivered 26,891 GEOs for Q4 2024, almost 70% higher than the prior year and twice as many as Q3 2024 [23] Market Data and Key Metrics Changes - Gold prices increased by 34.7% in Q4 2024 and 22.9% for the full year [18] - The average cash cost per GEO for the full year 2024 was $278, down from $286 in 2023 [30] - The company expects a 25% increase in 2025 revenue over 2024, based on budgeted gold prices [35] Company Strategy and Development Direction - The company aims to continue its business development activities, having completed over $1.3 billion in acquisitions and commitments during 2024 [9] - New contributions from recent acquisitions and organic growth are expected to drive growth in the medium-term production profile [12] - The company is optimistic about developments in Panama, with indications of a willingness to discuss corporate matters [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong performance of the gold mining industry despite market volatility [95] - The company anticipates a stronger second half of 2025, with better performance expected as the year progresses [36] - Management highlighted the importance of maintaining a strong balance sheet to support future acquisitions [41] Other Important Information - The company has a substantial cash balance and no debt, allowing for continued dividend increases [14] - Legal proceedings related to Cobre Panama are expected to incur annual costs of approximately $10 million [40] Q&A Session Summary Question: Comments on Cobre Panama and arbitration - Management confirmed that separate arbitration processes exist and can be put on hold for a fixed timeframe if needed [45] - The company believes the previous deal was favorable for Panama, and any changes in ownership would not affect the stream calculation [50] Question: Delivery timing for Sibanye-Stillwater South African PGM Stream - The first delivery related to 2024 production will occur in Q1, while the delivery for 2025 production will be in Q2 due to a 45-day delay [54] Question: Guidance for 2028 and 2029 - The drop in GEOs for 2029 is primarily due to the mine plan for Guadalupe and Palmarejo, with expectations of a 50% drop in production [105] Question: Energy division contribution to guidance - The energy division is expected to contribute around 16% to 17% of GEOs by 2029 [131] Question: Potential M&A opportunities - The company remains focused on precious metals for M&A opportunities, with a mix of potential deals in the $300 million to $500 million range [148]
netpower(NPWR) - 2024 Q4 - Earnings Call Transcript
2025-03-10 15:28
Financial Data and Key Metrics Changes - The company closed 2024 with $533 million in cash, down from approximately $580 million at the end of Q3, reflecting $13 million in operating cash outflows and $29 million in capital expenditures [50][51] - Total capital expenditures for the full year were roughly $70 million, with operating cash outflows of approximately $32 million [51][52] - The estimated total installed cost for Project Permian has increased to $1.7 billion to $2 billion, representing an approximately 100% increase from earlier estimates [14][15] Business Line Data and Key Metrics Changes - The completion of the front-end engineering and design (FEED) for Project Permian marked a significant milestone, with no fatal flaws identified in the technology or plant design [5][12] - The company has initiated a post-FEED optimization and value engineering exercise to reduce costs for Project Permian [8][37] - The La Porte demonstration facility has achieved over 140 fired hours of operation during the first phase of the equipment validation program [46] Market Data and Key Metrics Changes - The energy sector is experiencing unprecedented demand for reliable generation capacity, driven by underinvestment in power infrastructure and rapid load growth, particularly from AI and data centers [6][9] - The company anticipates that the market will remain tight through the end of the decade, with significant competition for new baseload generation solutions [96][100] Company Strategy and Development Direction - The company aims to be the lowest cost source of clean, firm power by focusing on cost optimization, modular design, and strategic partnerships [11][58] - Future priorities include completing feasibility studies for multi-unit projects along the Gulf Coast and seeking to raise capital for commercialization [19][21] - The company is exploring opportunities to unlock the embedded value of its technology through licensing and industrial-scale applications [27][48] Management's Comments on Operating Environment and Future Outlook - Management highlighted the challenges posed by inflationary pressures and tight supply chains in the energy sector, impacting project costs and timelines [11][16] - The company remains optimistic about its technology's potential to deliver clean, reliable, and affordable energy, despite current market challenges [57][58] - Management emphasized the importance of securing strategic capital partners to fund future projects and achieve economic commercialization [55][106] Other Important Information - The company is evaluating other creative ways to commercialize its technology, including partnerships for industrial applications [27][48] - The collaboration with Baker Hughes and Woodside Energy aims to develop an industrial-scale Net Power solution for smaller applications [47] Q&A Session Summary Question: Can you break out labor costs and productivity assumptions within the FEED? - Management indicated that they cannot provide a detailed breakdown but noted that market supply-demand imbalances and escalation in material and labor costs contributed to the increase [63][65] Question: How do you see thermal CapEx declining over the next several years? - Management expressed skepticism about CapEx deflation in the near term due to tight supply chains and emphasized the importance of multi-pack deployments for cost reductions [70][71] Question: Can you discuss milestones for modularization? - Management confirmed ongoing efforts to maximize modularization at Project Permian and plans to explore feasibility for future deployments [83] Question: Any updates on discussions with the DOE? - Management noted alignment with the current administration's focus on domestic energy security and the potential benefits of the 45Q tax credit [87][90] Question: How are financial partners approaching funding? - Management indicated that strategic partners are focused on the pathway to deploying Net Power units at scale, aligning with the 2030 to 2035 timeframe [105][106]
en & pany (COHN) - 2024 Q4 - Earnings Call Transcript
2025-03-10 15:03
Cohen & Company Inc. (NYSE:COHN) Q4 2024 Earnings Conference Call March 10, 2025 10:00 AM ET Company Participants Lester Brafman - CEO Joe Pooler - CFO Conference Call Participants Operator Good morning, ladies and gentlemen, and welcome to Cohen & Company's Fourth Quarter 2024 Earnings Call. My name is Sherry, and I will be your operator for today. Before we begin, Cohen & Company would like to remind everyone that some of the statements the company makes during this call contain forward-looking statements ...